BRPI0410422A - materiais e processos para para imunização contra infecção por fiv - Google Patents
materiais e processos para para imunização contra infecção por fivInfo
- Publication number
- BRPI0410422A BRPI0410422A BRPI0410422-6A BRPI0410422A BRPI0410422A BR PI0410422 A BRPI0410422 A BR PI0410422A BR PI0410422 A BRPI0410422 A BR PI0410422A BR PI0410422 A BRPI0410422 A BR PI0410422A
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- ivf
- materials
- immunization against
- compositions
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 5
- 238000002649 immunization Methods 0.000 title abstract 2
- 230000003053 immunization Effects 0.000 title abstract 2
- 239000000463 material Substances 0.000 title abstract 2
- 208000031886 HIV Infections Diseases 0.000 title 1
- 208000037357 HIV infectious disease Diseases 0.000 title 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 title 1
- 208000012404 paroxysmal familial ventricular fibrillation Diseases 0.000 abstract 4
- 241000282324 Felis Species 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 241000713711 Primate lentivirus group Species 0.000 abstract 1
- 230000024932 T cell mediated immunity Effects 0.000 abstract 1
- 230000028996 humoral immune response Effects 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
- C07K14/155—Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
- A61K2039/55538—IL-12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
"MATERIAIS E PROCESSOS PARA IMUNIZAçãO CONTRA INFECçãO POR FIV". A presente invenção refere-se aos processos e composições para proteção dos animais felinos contra infecção por FIV usando imunógenos derivados de vírus da imunodeficiência de primatas, incluindo HIV e SIV. São descritos os processos para vacinação de animais felinos com as presentes composições de vacina. Os animais felinos vacinados de acordo com os processos e composições da presente invenção exibem respostas imunes celulares e humorais protetoras para FIV quando desafiados com FIV.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47006603P | 2003-05-12 | 2003-05-12 | |
PCT/US2004/014928 WO2004100985A2 (en) | 2003-05-12 | 2004-05-12 | Materials and methods for immunizing against fiv infection |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0410422A true BRPI0410422A (pt) | 2006-05-30 |
Family
ID=33452358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0410422-6A BRPI0410422A (pt) | 2003-05-12 | 2004-05-12 | materiais e processos para para imunização contra infecção por fiv |
Country Status (14)
Country | Link |
---|---|
US (2) | US20050031639A1 (pt) |
EP (1) | EP1622644A2 (pt) |
JP (1) | JP2006528244A (pt) |
KR (1) | KR20060032138A (pt) |
CN (1) | CN100387301C (pt) |
AU (1) | AU2004238367A1 (pt) |
BR (1) | BRPI0410422A (pt) |
CA (1) | CA2525641A1 (pt) |
MX (1) | MXPA05012270A (pt) |
NO (1) | NO20055857L (pt) |
NZ (1) | NZ543381A (pt) |
RU (1) | RU2005138501A (pt) |
WO (1) | WO2004100985A2 (pt) |
ZA (1) | ZA200508853B (pt) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7658927B2 (en) * | 2003-05-12 | 2010-02-09 | University Of Florida Research Foundation, Inc. | Materials and methods for immunizing against FIV infection |
CA2525641A1 (en) | 2003-05-12 | 2004-11-25 | University Of Florida Research Foundation, Inc. | Materials and methods for immunizing against fiv infection |
US7776546B2 (en) | 2003-09-11 | 2010-08-17 | Idexx Laboratories, Inc. | Method and device for detecting feline immunodeficiency virus |
EP1709447B1 (en) | 2003-12-18 | 2009-06-24 | Idexx Laboratories, Inc. | Method for detecting feline immunodeficiency virus |
EP1723425B1 (en) | 2004-02-19 | 2011-04-06 | Idexx Laboratories, Inc. | Method and device for detecting feline immunodeficiency virus |
WO2006011920A1 (en) | 2004-06-30 | 2006-02-02 | Idexx Laboratories, Inc. | Method and device for detecting feline immunodeficiency virus (fiv) comprising the use of peptides derived from the v3 region of the fiv env protein |
EP1761564A1 (en) * | 2004-06-30 | 2007-03-14 | Idexx Laboratories, Inc. | Method and device for detecting feline immunodeficiency virus |
CA2576902C (en) | 2004-06-30 | 2012-05-08 | Idexx Laboratories, Inc. | Method and device for detecting feline immunodeficiency virus |
US7291338B2 (en) | 2005-03-09 | 2007-11-06 | Idexx Laboratories, Inc. | Method and device for detecting feline immunodeficiency virus |
EP2553452B1 (en) | 2010-04-02 | 2015-03-04 | IDEXX Laboratories, Inc. | Detection of feline immunodeficiency virus |
WO2013040766A1 (zh) * | 2011-09-21 | 2013-03-28 | 中国疾病预防控制中心性病艾滋病预防控制中心 | 可诱导针对hiv的广谱免疫应答的方法和疫苗 |
JP2013116869A (ja) * | 2011-12-02 | 2013-06-13 | Vaxxinova Kk | 細胞内在ウイルスを主成分とする伝染性ファブリキウス嚢病生ワクチン |
JP2018528974A (ja) * | 2015-09-25 | 2018-10-04 | フロリダ大学 リサーチファウンデーション インコーポレイティッド | ヒトおよびネコにおけるワクチンのためのhiv、sivおよびfivの交差反応性t細胞エピトープ |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4861720A (en) * | 1986-07-03 | 1989-08-29 | Regents Of The University Of California | Oncornavirus vaccines and feline alpha-type interferon |
US5118602A (en) * | 1987-08-26 | 1992-06-02 | The Regents Of The University Of California | Feline T-lymphotropic lentivirus assay |
CA1341439C (en) * | 1987-08-26 | 2003-09-23 | Niels C. Pedersen | Feline t-lymphotropic lentivirus |
US6107077A (en) * | 1987-08-26 | 2000-08-22 | Yamamoto; Janet K. | Feline lymphoid cell lines capable of producing FIV for FIV diagnostics and vaccines |
US5763160A (en) * | 1988-02-12 | 1998-06-09 | United Biomedical, Inc. | Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines |
US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
US5480967A (en) * | 1990-01-05 | 1996-01-02 | United Biomedical, Inc. | HIV-1 core protein fragments |
WO1991015238A1 (en) * | 1990-04-03 | 1991-10-17 | Genentech, Inc. | Methods and compositions for vaccination against hiv |
US5766598A (en) * | 1991-03-07 | 1998-06-16 | Virogenetics Corporation | Recombinant attenuated ALVAC canarypoxvirus expression vectors containing heterologous DNA segments encoding lentiviral gene products |
US5229364A (en) * | 1991-03-15 | 1993-07-20 | Francesca Chiodi | Polypeptides derived from the human immunodeficiency virus endonuclease protein |
JP4124480B2 (ja) * | 1991-06-14 | 2008-07-23 | ジェネンテック・インコーポレーテッド | 免疫グロブリン変異体 |
AU2299892A (en) | 1991-07-05 | 1993-02-11 | Regents Of The University Of California, The | Feline lymphoid cell lines capable of producing fiv |
EP0670901A1 (en) | 1993-03-11 | 1995-09-13 | Akzo Nobel N.V. | Polypeptide fragment capable of inducing neutralising antibodies against feline immuno-deficiency virus |
NZ267838A (en) | 1993-06-07 | 1997-12-19 | Genentech Inc | Preparation of an hiv gp 120 subunit vaccine involving determining a neutralising epitope in the v2 and/or c4 domains |
IT1276509B1 (it) | 1995-03-31 | 1997-10-31 | Istituto Superiore Della Sanit | Vaccino per la profilassiimmunitaria dell'infezione da virus della immunodeficienza felina del gatto domestico. |
EP0759468A1 (en) * | 1995-08-10 | 1997-02-26 | Laboratoires Virbac | Feline interleukin-4 |
AU728750B2 (en) * | 1995-08-25 | 2001-01-18 | Regents Of The University Of California, The | Multi-subtype FIV vaccines |
US6254872B1 (en) * | 1995-08-25 | 2001-07-03 | University Of Florida | Multi-subtype FIV vaccines |
US5741492A (en) * | 1996-01-23 | 1998-04-21 | St. Jude Children's Research Hospital | Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses |
ZA973642B (en) * | 1996-04-26 | 1997-11-25 | Merck & Co Inc | DNA vaccine formulations. |
EP1045921A2 (en) * | 1998-01-16 | 2000-10-25 | Chiron Corporation | Feline immunodeficiency virus gene therapy vectors |
US6503753B1 (en) * | 1998-02-13 | 2003-01-07 | Adan Rios | Method for the development of an HIV vaccine |
EP1078105B1 (en) * | 1998-05-12 | 2004-11-24 | Genecure LLC | Replication defective hiv vaccine |
US6602705B1 (en) * | 1998-12-31 | 2003-08-05 | Chiron Corporation | Expression of HIV polypeptides and production of virus-like particles |
EP1074625A3 (en) * | 1999-06-14 | 2002-01-02 | Pfizer Products Inc. | DNA vaccine against feline immunodeficiency virus |
KR100354562B1 (ko) * | 1999-12-06 | 2002-09-30 | 주식회사 제넥신 | 원숭이에서 SIVmac239의 감염에 대한 방어를유도하는 AIDS DNA 백신 |
JP2004502721A (ja) * | 2000-07-07 | 2004-01-29 | コリクサ コーポレイション | Dnaワクチン送達のためのミクロスフェアおよびアジュバント |
WO2002067984A2 (en) * | 2001-02-22 | 2002-09-06 | University Of Florida | Materials and methods for detecting, preventing, and treating hiv and fiv retroviral infection |
US7658927B2 (en) * | 2003-05-12 | 2010-02-09 | University Of Florida Research Foundation, Inc. | Materials and methods for immunizing against FIV infection |
CA2525641A1 (en) | 2003-05-12 | 2004-11-25 | University Of Florida Research Foundation, Inc. | Materials and methods for immunizing against fiv infection |
-
2004
- 2004-05-12 CA CA002525641A patent/CA2525641A1/en not_active Abandoned
- 2004-05-12 MX MXPA05012270A patent/MXPA05012270A/es unknown
- 2004-05-12 EP EP04752057A patent/EP1622644A2/en not_active Withdrawn
- 2004-05-12 BR BRPI0410422-6A patent/BRPI0410422A/pt not_active IP Right Cessation
- 2004-05-12 KR KR1020057021578A patent/KR20060032138A/ko not_active Application Discontinuation
- 2004-05-12 NZ NZ543381A patent/NZ543381A/en unknown
- 2004-05-12 CN CNB2004800182432A patent/CN100387301C/zh not_active Expired - Fee Related
- 2004-05-12 US US10/844,658 patent/US20050031639A1/en not_active Abandoned
- 2004-05-12 RU RU2005138501/13A patent/RU2005138501A/ru not_active Application Discontinuation
- 2004-05-12 JP JP2006533010A patent/JP2006528244A/ja active Pending
- 2004-05-12 AU AU2004238367A patent/AU2004238367A1/en not_active Abandoned
- 2004-05-12 WO PCT/US2004/014928 patent/WO2004100985A2/en active Search and Examination
-
2005
- 2005-11-01 ZA ZA200508853A patent/ZA200508853B/xx unknown
- 2005-12-09 NO NO20055857A patent/NO20055857L/no not_active Application Discontinuation
-
2009
- 2009-10-07 US US12/575,058 patent/US8703145B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US8703145B2 (en) | 2014-04-22 |
NZ543381A (en) | 2008-04-30 |
AU2004238367A2 (en) | 2004-11-25 |
CA2525641A1 (en) | 2004-11-25 |
ZA200508853B (en) | 2007-02-28 |
CN1812810A (zh) | 2006-08-02 |
MXPA05012270A (es) | 2006-02-10 |
AU2004238367A1 (en) | 2004-11-25 |
RU2005138501A (ru) | 2006-06-27 |
WO2004100985A3 (en) | 2005-03-24 |
US20100111899A1 (en) | 2010-05-06 |
NO20055857L (no) | 2006-02-10 |
CN100387301C (zh) | 2008-05-14 |
EP1622644A2 (en) | 2006-02-08 |
US20050031639A1 (en) | 2005-02-10 |
JP2006528244A (ja) | 2006-12-14 |
WO2004100985A2 (en) | 2004-11-25 |
KR20060032138A (ko) | 2006-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20055857L (no) | Materialer og fremgangsmater til immunisering mot FIV-infeksjon | |
EP2130921A3 (en) | Vaccine for prevention and treatment of hiv-infection | |
WO2005116270A3 (en) | Influenza virus vaccine composition and method of use | |
WO2006068663A3 (en) | Vaccine compositions for treating coronavirus infection | |
HUP0401606A2 (hu) | West Nile vakcina | |
WO2002032943A3 (en) | Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization | |
DK1523582T3 (da) | Hurtig, effektiv rensning af HSV-specifikke T-lymfocytter samt HSV-antigener identificeret derved | |
PT848615E (pt) | Vacinas de fiv de multiplos subtipos | |
IL182440A0 (en) | Subtype-matched inactivated whole virus vaccines for treating patients with hiv infection | |
ATE458496T1 (de) | Hiv-vakzine und anwendungsverfahren | |
AR032871A1 (es) | Poxvirus recombinantes para proteinas quimericas del virus de la inmunodeficiencia humana | |
RU2014140731A (ru) | Варианты гемагглютинина и нейраминидазы гриппа | |
AU6683400A (en) | Vaccine against lentiviral infections, such as the feline immune deficiency virus of the cat | |
WO2005097179A3 (fr) | Antigene tat stabilise et ses applications pour la vaccination anti-vih. | |
MXPA03009763A (es) | Vacuna contra el virus de la enfermedad de la fiebre aftosa. | |
WO2005027844A3 (en) | Dna vaccine compositions and methods of use | |
WO2007079457A3 (en) | Materials and methods for immunizing against fiv infection | |
WO2003080112A3 (en) | Imidazoquinolineamines as adjuvants in hiv dna vaccination | |
KR101863335B1 (ko) | 어류 바이러스성 출혈성 패혈증에 대한 예방 또는 치료용 dna 백신 | |
CY1107374T1 (el) | Εμβολιο ιχθυος εναντι της piscirickettsia salmonis | |
RU2007142203A (ru) | Вакцина против кокцидий и способы ее получения и применение | |
WO2023094885A3 (en) | Antigenic determinants, protective immunity, serodiagnostic and multivalent subunits precision vaccine against sars-cov-2 | |
Pushko et al. | Live attenuated Venezuelan Equine encephalitis vaccine | |
ATE439858T1 (de) | Vakzine zum schutz von tieren gegen leishmania | |
TH67155A3 (th) | องค์ประกอบและวิธีการสำหรับการป้องกันสัตว์จากโรคที่เกี่ยวกับแลนติไวรัส ดังเช่น ไวรัสภูมิคุ้มกันบกพร่องในแมว |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A, 7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012. |